Nahid Ali
Nahid Ali
Professor in Infectious Diseases and Immunology Department
Verified email at iicb.res.in
Title
Cited by
Cited by
Year
IL-10-and TGF-β-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection …
S Saha, S Mondal, R Ravindran, S Bhowmick, D Modak, S Mallick, ...
The Journal of Immunology 179 (8), 5592-5603, 2007
1532007
Adjuvanticity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes.
F Afrin, N Ali
Infection and immunity 65 (6), 2371-2377, 1997
1221997
gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani
S Bhowmick, R Ravindran, N Ali
Infection and immunity 76 (3), 1003-1015, 2008
1102008
Immune responses in kala-azar
S Saha, S Mondal, A Banerjee, J Ghose, S Bhowmick, N Ali
Indian Journal of Medical Research 123 (3), 245, 2006
1072006
Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB/c mice
F Afrin, R Rajesh, K Anam, M Gopinath, S Pal, N Ali
Infection and immunity 70 (12), 6697-6706, 2002
1072002
Vaccines for the leishmaniases: proposals for a research agenda
CHN Costa
1022011
Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response
S Bhowmick, R Ravindran, N Ali
Vaccine 25 (35), 6544-6556, 2007
992007
Current diagnosis and treatment of visceral leishmaniasis
S Mondal, P Bhattacharya, N Ali
Expert review of anti-infective therapy 8 (8), 919-944, 2010
972010
A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice
T Mazumdar, K Anam, N Ali
Vaccine 22 (9-10), 1162-1171, 2004
942004
Comparison of liposome based antigen delivery systems for protection against Leishmania donovani
S Bhowmick, T Mazumdar, R Sinha, N Ali
Journal of controlled release 141 (2), 199-207, 2010
802010
Potency, efficacy and durability of DNA/DNA, DNA/protein and protein/protein based vaccination using gp63 against Leishmania donovani in BALB/c mice
S Mazumder, M Maji, A Das, N Ali
PloS one 6 (2), e14644, 2011
762011
Differential decline in Leishmania membrane antigen-specific immunoglobulin G (IgG), IgM, IgE, and IgG subclass antibodies in Indian kala-azar patients after chemotherapy
K Anam, F Afrin, D Banerjee, N Pramanik, SK Guha, RP Goswami, ...
Infection and immunity 67 (12), 6663-6669, 1999
711999
Complete cure of experimental visceral leishmaniasis with amphotericin B in stearylamine-bearing cationic liposomes involves down-regulation of IL-10 and favorable T cell responses
A Banerjee, M De, N Ali
The Journal of Immunology 181 (2), 1386-1398, 2008
662008
Identification of novel Leishmania donovani antigens that help define correlates of vaccine-mediated protection in visceral leishmaniasis
S Bhowmick, N Ali
PloS one 4 (6), e5820, 2009
642009
Influence of phospholipid composition on the adjuvanticity and protective efficacy of liposome-encapsulated Leishmania donovani antigens
T Mazumdar, K Anam, N Ali
Journal of Parasitology 91 (2), 269-274, 2005
592005
Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis
R Ravindran, S Bhowmick, A Das, N Ali
BMC microbiology 10 (1), 1-10, 2010
552010
Progress in vaccine research and possible effector mechanisms in visceral leishmaniasis
R Ravindran, N Ali
Current molecular medicine 4 (6), 697-709, 2004
542004
Immunoglobulin subclass distribution and diagnostic value of Leishmania donovani antigen-specific immunoglobulin G3 in Indian kala-azar patients
K Anam, F Afrin, D Banerjee, N Pramanik, SK Guha, RP Goswami, ...
Clinical and diagnostic laboratory immunology 6 (2), 231-235, 1999
531999
Vaccine development against Leishmania donovani
A Das, N Ali
Frontiers in immunology 3, 99, 2012
522012
In vitro induction of nitric oxide by mouse peritoneal macrophages treated with human placental extract
PD Chakraborty, D Bhattacharyya, S Pal, N Ali
International immunopharmacology 6 (1), 100-107, 2006
522006
The system can't perform the operation now. Try again later.
Articles 1–20